Aquestive Therapeutics Inc
(AQST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 12,807 | 10,003 | 8,720 | 11,867 | 13,542 |
| Cost of Goods | 4,506 | 4,561 | 3,652 | 4,520 | 4,437 |
| Gross Profit | 8,301 | 5,442 | 5,068 | 7,347 | 9,105 |
| Operating Expenses | 20,286 | 17,371 | 25,085 | 21,446 | 17,832 |
| Operating Income | -11,479 | -11,368 | -19,365 | -13,579 | -8,290 |
| Interest Expense | 4,273 | 4,276 | 4,278 | 4,224 | 4,198 |
| Other Income | 306 | 2,096 | 713 | 734 | 979 |
| Pre-tax Income | -15,446 | -13,548 | -22,930 | -17,069 | -11,509 |
| Net Income Continuous | -15,446 | -13,548 | -22,930 | -17,055 | -11,509 |
| Net Income | $-15,446 | $-13,548 | $-22,930 | $-17,055 | $-11,509 |
| EPS Basic Total Ops | -0.14 | -0.14 | -0.24 | -0.18 | -0.13 |
| EPS Basic Continuous Ops | -0.14 | -0.14 | -0.24 | -0.18 | -0.13 |
| EPS Diluted Total Ops | -0.14 | -0.14 | -0.24 | -0.18 | -0.13 |
| EPS Diluted Continuous Ops | -0.14 | -0.14 | -0.24 | -0.18 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 |
| EBITDA(a) | $-8,592 | $-8,480 | $-16,476 | $-10,733 | $-5,458 |